Table 3.
Analyte | Units | Control | 2 × NRC RA | 4 × NRC RA | 6 × NRC RA | 8 × NRC RA | P Dose |
---|---|---|---|---|---|---|---|
TAG | mmol/L | 0.37 ± 0.04b | 0.39 ± 0.04ab | 0.42 ± 0.04ab | 0.46 ± 0.04a | 0.38 ± 0.04ab | 0.027 |
CHOL | mmol/L | 6.65 ± 0.35b | 6.58 ± 0.35b | 6.83 ± 0.35ab | 7.15 ± 0.35a | 6.90 ± 0.35ab | 0.012 |
HDL-C | mmol/L | 5.20 ± 0.20b | 5.28 ± 0.20ab | 5.40 ± 0.20ab | 5.54 ± 0.20a | 5.42 ± 0.20ab | 0.026 |
LDL-C | mmol/L | 1.29 ± 0.18 | 1.13 ± 0.18 | 1.24 ± 0.18 | 1.40 ± 0.18 | 1.31 ± 0.18 | 0.066 |
VLDL | mmol/L | 0.17 ± 0.02b | 0.18 ± 0.02ab | 0.19 ± 0.02ab | 0.21 ± 0.02a | 0.17 ± 0.02ab | 0.027 |
NEFA | mmol/L | 0.22 ± 0.02 | 0.23 ± 0.02 | 0.21 ± 0.02 | 0.20 ± 0.02 | 0.17 ± 0.02 | 0.071 |
ALP | U/L | 26.88 ± 2.98a | 26.37 ± 2.98a | 26.35 ± 2.98a | 24.55 ± 2.98ab | 23.20 ± 2.98b | 0.004 |
ALT | U/L | 51.23 ± 4.88 | 45.50 ± 4.88 | 54.36 ± 4.88 | 48.88 ± 4.88 | 60.18 ± 4.88 | 0.134 |
CREAT | mmol/L | 114.06 ± 2.92 | 114.63 ± 2.92 | 111.44 ± 2.92 | 112.79 ± 2.92 | 114.08 ± 2.92 | 0.702 |
GLUC | mmol/L | 9.73 ± 0.82 | 9.06 ± 0.82 | 9.45 ± 0.82 | 8.35 ± 0.82 | 9.37 ± 0.82 | 0.373 |
BUN | mmol/L | 8.16 ± 0.23a | 8.00 ± 0.23ab | 7.75 ± 0.23b | 7.86 ± 0.23ab | 7.82 ± 0.23b | 0.006 |
Values expressed as LSM ± SEM; values in a row with superscripts without a common letter differ; P < 0.05, repeated measures ANOVA with Tukey post hoc test. NRC, National Research Council; RA, recommended allowance; BW, body weight; TAG, triglycerides; CHOL, cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL, very low-density lipoprotein cholesterol; NEFA, non-esterified fatty acids; ALP, alkaline phosphatase; ALT, alanine aminotransferase; CREAT, creatinine; GLUC, glucose; BUN, blood urea nitrogen.